Which test gets blood thinner dosing right faster? hospital study aims to find out
NCT ID NCT06329921
First seen Dec 16, 2025 · Last updated Jun 13, 2026 · Updated 23 times
Summary
This study compares two blood tests (PTT and anti-Xa) used to monitor the blood thinner heparin in hospitalized patients with blood clots. The goal is to see which test helps doctors adjust the medication to the right level more quickly. About 700 adults at Vanderbilt University Hospital will take part, and the results may improve how heparin is managed in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THROMBOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.